Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01934309
Other study ID # AID-OAA-TO-11-00060
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2013
Est. completion date August 2014

Study information

Verified date March 2023
Source Indiana University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The overall research objective is to evaluate the impact of implementing a reminder system for medical providers to improve TB case-finding and isoniazid preventative therapy (IPT) for adults living with HIV in western Kenya


Description:

The purpose of this study is to evaluate the impact of implementing a clinical decision support reminder system for medical providers (i.e., nurses, clinical officers, medical officers, consultants) to improve tuberculosis case-finding and the use of isoniazid preventative therapy for adults living with HIV in western Kenya.


Recruitment information / eligibility

Status Completed
Enrollment 3782
Est. completion date August 2014
Est. primary completion date August 2014
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Clusters: Inclusion Criteria - active - uses HIV initial and return encounter paper forms - enters data into the AMPATH medical records system (AMRS) or sends forms to central location for data entry - prints or receives printed paper summary sheets with reminders - interprets chest x-rays - interprets sputum smear results - prescribes IPT and dispenses INH - completed an average of 10 initial adult HIV positive encounters per month in 2012 - HIV Care Clinic Exclusion Criteria - Patients: Inclusion Criteria - HIV positive - complete an adult initial encounter at an HIV Care Clinic during the enrollment period - attend at least one additional appointment within 90 days after the initial encounter Exclusion Criteria - history of TB or IPT

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
TB reminders
The intervention to be studied involves providing clinic-based medical care providers (e.g., nurses, clinical officers, medical officers, consultants) with patient-speci?c clinical reminders regarding TB that are generated from a patient's electronic medical record and based on accepted clinical algorithms for TB screening and treatment.

Locations

Country Name City State
Kenya AMPATH Eldoret

Sponsors (6)

Lead Sponsor Collaborator
Indiana University Academic Model Providing Access to Healthcare (AMPATH), Innovative Support to Emergencies, Diseases and Disasters (InSTEDD), Kijani Consulting, Moi University, Regenstrief Institute, Inc.

Country where clinical trial is conducted

Kenya, 

Outcome

Type Measure Description Time frame Safety issue
Other Initiation of isoniazid prophylactic therapy (IPT) IPT will be considered "initiated" when a patient picks up the initial batch of the prescribed medications within 3 months of the initial encounter. within 3 months of initial encounter
Other Isoniazid prophylactic therapy (IPT) completion Patient completes 9-month course of IPT 9 months after treatment initiation
Primary Prescription of Isoniazid Provider prescribes INH within 3 months of patient's initial encounter. within 3 months of initial encounter
Secondary Time to isoniazid prophylactic therapy (IPT) initiation The time in weeks from a patient's initial encounter to the week the patient picks up the initial batch of INH from the pharmacy. within 3 months of initial encounter
See also
  Status Clinical Trial Phase
Recruiting NCT05738681 - Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial Phase 2/Phase 3
Recruiting NCT05526885 - Tuberculosis Diagnostic Trial of CAD4TB Screening Alone Compared to CAD4TB Screening Combined With a CRP Triage Test, Both Followed by Confirmatory Xpert MTB/RIF Ultra in Communities of Lesotho and South Africa N/A
Completed NCT04369326 - Community Initiated Preventive Therapy for TB N/A
Recruiting NCT04568967 - TB-CAPT EXULTANT - HIV N/A
Completed NCT02337270 - Phase 1 Clinical Trial of the Safety and Immunogenicity of an Adenovirus-based TB Vaccine Administered by Aerosol Phase 1
Not yet recruiting NCT06253715 - Shortened Regimen for Drug-susceptible TB in Children Phase 3
Recruiting NCT04271397 - Immunological Biomarkers in Tuberculosis Management N/A
Withdrawn NCT03639038 - Tuberculosis Diagnosis by Flow Cytometry
Completed NCT03199313 - Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid Phase 1
Recruiting NCT04975178 - Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa Phase 3
Completed NCT04463680 - Rifampin and the Contraceptive Implant Phase 4
Completed NCT03973970 - Assessing the Ability of the T-SPOT®.TB Test (IQ)
Recruiting NCT04230395 - Alcohol Reduction Among People With TB and HIV in India N/A
Completed NCT04874948 - Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment Phase 1
Active, not recruiting NCT02906007 - Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV Phase 1/Phase 2
Not yet recruiting NCT05917210 - Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda N/A
Not yet recruiting NCT06017843 - Impact Evaluation of Use of MATCH AI Predictive Modelling for Identification of Hotspots for TB Active Case Finding N/A
Not yet recruiting NCT05845112 - Start Taking Action For TB Diagnosis
Active, not recruiting NCT02715271 - Study of TB Lesions Obtained in Therapeutical Surgery
Completed NCT02781909 - Potential Efficacy and Safety of Using Adjunctive Ibuprofen for XDR-TB Tuberculosis Phase 2